Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-178730
Filing Date
2013-04-29
Accepted
2013-04-26 21:40:30
Documents
4
Period of Report
2013-05-29
Effectiveness Date
2013-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d484784ddef14a.htm DEF 14A 1014285
2 GRAPHIC g484784g12t42.jpg GRAPHIC 183226
3 GRAPHIC g484784g67q95.jpg GRAPHIC 128359
4 GRAPHIC g484784g97e79.jpg GRAPHIC 59696
  Complete submission text file 0001193125-13-178730.txt   1527332
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 13788852
SIC: 2834 Pharmaceutical Preparations